Today on Outsourcing-Pharma.com   GSK blocks new patent rules UK updates clinical trial negotiation system to include CROs Inyx drama highlights crucial need for due diligence on contractors Parexel profits perky in Q1 Clinical contract news in brief

Related Industry News   Treating cancer as infectious disease yields results Once-weekly diabetes treatment looking good Premature ejaculation spray coming to clinical climax Chemical trigger of Parkinson's found

Breaking News on Outsourcing Pharma
Daily  Thursday 01 November 2007		Forward to a colleague

	Technical / White Paper Benefits of integrating human tissue research in drug discovery The benefits of integrating human tissue research into drug discovery and development programs are in the confidence that they provide in the selection of the NCEs most likely to succeed in the clinic, and doing this in the most financially efficient way... Click Here Access Full Stories GSK blocks new patent rules Just a day before they were due to come into force, GlaxoSmithKline has won a court case to block controversial changes to patent rules... Read UK updates clinical trial negotiation system to include CROs An update to the contract negotiation system for hospital-based clinical trials has come into play in the UK - in a further effort to take some of the pain out of the process and speed up trial start-up times... Read Inyx drama highlights crucial need for due diligence on contractors There are lessons to be learned about the importance of rigorous due diligence of pharma contractors, now that Inyx' customers are facing possible supply issues and a scramble to find alternative manufacturers... Read Parexel profits perky in Q1 Parexel has seen its profits remain perky during its first financial quarter of 2008... Read Clinical contract news in brief Outsourcing-Pharma.com compiles the news that featured in the clinical contract community this past week, involving PPD, Novotech and Generex... Read
	All News Headlines for: November | October | September
	Related Industry News Treating cancer as infectious disease yields results For the first time, scientists have found a way to target viral antigens deep inside a cancer tumour, and the result is a new therapy that could treat or even prevent the disease... Read Once-weekly diabetes treatment looking good A once-weekly Type II diabetes treatment has shown promise when compared to its twice-daily counterpart... Read Premature ejaculation spray coming to clinical climax A nifty spray-on solution could make all the difference for men plagued with the problem of climaxing too soon, as the product makes its final thrust in clinical development... Read Chemical trigger of Parkinson's found A group of scientists believe they have cracked the riddle of how Parkinson's disease is triggered - a breakthrough that could lead to more effective therapies against the disease... Read Weekly Comment Pfizer partners in shock after surprise Exubera exit We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find out the product was being scrapped through a press release. Read Previous Headlines Nycomed to acquire Bradley Nycomed is to acquire Bradley Pharmaceuticals for $346m (€240m) in a bid to make a niche for itself in the dermatology market... Read Covance posts healthy 3Q growth Covance is feeling positive after reporting healthy growth in both business units for the third quarter, with its early phase segment continuing to have the edge over its late stage unit... Read Karma for big pharma? Sanofi-Aventis caught out by Inyx collapse Sanofi-Aventis has had to take Inyx USA to court after it failed to deliver on a contract manufacturing and supply agreement, a situation that Aventis feared could "seriously harm its interests". There may be important... Read Explosions at two pharma plants Two pharmaceutical companies have faced explosions at their plants in the last week, local media reported... Read Big pharma reaches to Summit for zebrafish safety screening Summit (formerly Vastox) has signed a $450,000 (€312,000) deal with one of the world's top five pharma firms to enable it to use Summit's zebrafish-platform in its drug safety programme... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com